Image from Google Jackets

Coagulation disorders [electronic resource] : quality in laboratory diagnosis

By: Series: Diagnostic standards of carePublication details: New York : Demos Medical Pub., c2011.Description: 1 online resource (xii, 145 p.)ISBN:
  • 9781617050220 (electronic bk.)
  • 1617050229 (electronic bk.)
Subject(s): NLM classification:
  • 2011 A-427
  • WH 322
Online resources:
Contents:
Monitoring of anticoagulant therapy and patients being treated with warfarin -- Monitoring of anticoagulant therapy in patients being treated with unfractionated heparin -- Monitoring of anticoagulant therapy in patients being treated with low molecular weight heparin -- Monitoring of anticoagulant therapy in patients being treated with fondaparinux -- Monitoring of anticoagulant therapy in patients being treated with lepirudin or argatroban -- Evaluation for heparin induced thrombocytopenia -- Evaluation of prolongations of the PT and the PTT, and assessment for deficiencies of coagulation factors -- Evaluation for disseminated intravascular coagulation -- Evaluation for a congenital hypercoagulable state -- Evaluation for antiphospholipid antibodies -- Evaluation for von Willebrand disease -- Evaluation for a coagulation factor VIII inhibitor -- Evaluation for thrombocytopenia that is not associated with heparin exposure -- Evaluation for platelet dysfunction in the presence or absence of antiplatelet agents.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Home library Class number URL Status Date due Barcode
Electronic book Stenhouse Library Link to resource Available

Includes bibliographical references and index.

Monitoring of anticoagulant therapy and patients being treated with warfarin -- Monitoring of anticoagulant therapy in patients being treated with unfractionated heparin -- Monitoring of anticoagulant therapy in patients being treated with low molecular weight heparin -- Monitoring of anticoagulant therapy in patients being treated with fondaparinux -- Monitoring of anticoagulant therapy in patients being treated with lepirudin or argatroban -- Evaluation for heparin induced thrombocytopenia -- Evaluation of prolongations of the PT and the PTT, and assessment for deficiencies of coagulation factors -- Evaluation for disseminated intravascular coagulation -- Evaluation for a congenital hypercoagulable state -- Evaluation for antiphospholipid antibodies -- Evaluation for von Willebrand disease -- Evaluation for a coagulation factor VIII inhibitor -- Evaluation for thrombocytopenia that is not associated with heparin exposure -- Evaluation for platelet dysfunction in the presence or absence of antiplatelet agents.

Description based on print version record.

There are no comments on this title.

to post a comment.
London Health Libraries Koha Consortium privacy notice